The introduction of a new high-sensitivity troponin immunoassay might revolutionize the way acute coronary syndrome is diagnosed. The high analytical sensitivity of the assay enables earlier and more accurate identification of myocardial injury than with currently used methods, and also allows for the safe discharge of patients without myocardial ischaemia
The timely diagnosis of acute coronary syndrome (ACS), in particular myocardial infarction (MI), is ...
According to recently published expert guidelines, cardiac troponins are the only accepted biomarker...
In the past years, new generations of assays to detect cardiac troponin (cTn), called sensitive or h...
Cardiac troponins (cTn) are considered to be the ‘gold standard’ biomarker for the diagnosis of acut...
Current diagnostic biomarkers for ACS are mainly represented by troponin I and troponin T. Dosing of...
Cardiac troponins (cTn) are considered to be the ‘gold standard’ biomarkers for the diagnosis of acu...
The diagnosis of myocardial infarction (MI) depends on a rise and/or fall of cardiac biomarkers such...
W ith advances in technology, a new era in troponinassays is approaching. Previous-generation tropon...
The diagnosis of acute coronary syndrome (ACS) has challenged the minds of cardiologists, emergency ...
The timely diagnosis of acute coronary syndrome (ACS), in particular myocardial infarction (MI), is ...
The development of assays to detect plasma elevations of cardiac troponins has revolutionized our cu...
A timely and efficient diagnosis is critical in patients with chest pain, to optimize the efficacy o...
Nowadays, measurement of cardiac troponins (cTn) in patient plasma is central for diagnosis of patie...
AbstractIn the past years, new generations of assays to detect cardiac troponin (cTn), called sensit...
AbstractOver the past decade, there has been a progressive evolution of cardiac marker testing in pa...
The timely diagnosis of acute coronary syndrome (ACS), in particular myocardial infarction (MI), is ...
According to recently published expert guidelines, cardiac troponins are the only accepted biomarker...
In the past years, new generations of assays to detect cardiac troponin (cTn), called sensitive or h...
Cardiac troponins (cTn) are considered to be the ‘gold standard’ biomarker for the diagnosis of acut...
Current diagnostic biomarkers for ACS are mainly represented by troponin I and troponin T. Dosing of...
Cardiac troponins (cTn) are considered to be the ‘gold standard’ biomarkers for the diagnosis of acu...
The diagnosis of myocardial infarction (MI) depends on a rise and/or fall of cardiac biomarkers such...
W ith advances in technology, a new era in troponinassays is approaching. Previous-generation tropon...
The diagnosis of acute coronary syndrome (ACS) has challenged the minds of cardiologists, emergency ...
The timely diagnosis of acute coronary syndrome (ACS), in particular myocardial infarction (MI), is ...
The development of assays to detect plasma elevations of cardiac troponins has revolutionized our cu...
A timely and efficient diagnosis is critical in patients with chest pain, to optimize the efficacy o...
Nowadays, measurement of cardiac troponins (cTn) in patient plasma is central for diagnosis of patie...
AbstractIn the past years, new generations of assays to detect cardiac troponin (cTn), called sensit...
AbstractOver the past decade, there has been a progressive evolution of cardiac marker testing in pa...
The timely diagnosis of acute coronary syndrome (ACS), in particular myocardial infarction (MI), is ...
According to recently published expert guidelines, cardiac troponins are the only accepted biomarker...
In the past years, new generations of assays to detect cardiac troponin (cTn), called sensitive or h...
DOI
Add to ORKG